0001567619-21-004514.txt : 20210219
0001567619-21-004514.hdr.sgml : 20210219
20210219170050
ACCESSION NUMBER: 0001567619-21-004514
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210217
FILED AS OF DATE: 20210219
DATE AS OF CHANGE: 20210219
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MAZELSKY JONATHAN JAY
CENTRAL INDEX KEY: 0001556270
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19271
FILM NUMBER: 21656891
MAIL ADDRESS:
STREET 1: ONE IDEXX DRIVE
CITY: WESTBROOK
STATE: ME
ZIP: 04092
FORMER NAME:
FORMER CONFORMED NAME: MAZELSKY JAY
DATE OF NAME CHANGE: 20120815
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IDEXX LABORATORIES INC /DE
CENTRAL INDEX KEY: 0000874716
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 010393723
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE IDEXX DRIVE
CITY: WESTBROOK
STATE: ME
ZIP: 04092-2041
BUSINESS PHONE: 2075560300
MAIL ADDRESS:
STREET 1: ONE IDEXX DRIVE
CITY: WESTBROOK
STATE: ME
ZIP: 04092-2041
FORMER COMPANY:
FORMER CONFORMED NAME: IDEXX CORP / DE
DATE OF NAME CHANGE: 19600201
4
1
doc1.xml
FORM 4
X0306
4
2021-02-17
0
0000874716
IDEXX LABORATORIES INC /DE
IDXX
0001556270
MAZELSKY JONATHAN JAY
ONE IDEXX DRIVE
WESTBROOK
ME
04092
1
1
0
0
President & CEO
Common Stock
2021-02-17
4
M
0
25000
52
A
68090
D
Common Stock
2021-02-17
4
S
0
3940
535.9391
D
64150
D
Common Stock
2021-02-17
4
S
0
5376
536.7803
D
58744
D
Common Stock
2021-02-17
4
S
0
3069
537.8393
D
55705
D
Common Stock
2021-02-17
4
S
0
500
538.83
D
55205
D
Common Stock
2021-02-17
4
S
0
300
540.8226
D
54905
D
Common Stock
2021-02-17
4
S
0
583
542.0814
D
54322
D
Common Stock
2021-02-17
4
S
0
100
543.14
D
54222
D
Non-Qualified Stock Option (right-to-buy)
52
2021-02-17
4
M
0
25000
D
2023-12-04
Common Stock
25000
24002
D
Represents the weighted average price of the shares sold ranging from a low of $535.325 to a high of $536.28 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Represents the weighted average price of the shares sold ranging from a low of $536.33 to a high of $537.31 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Represents the weighted average price of the shares sold ranging from a low of $537.388 to a high of $538.12 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Represents the weighted average price of the shares sold ranging from a low of $540.218 to a high of $541.21 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Represents the weighted average price of the shares sold ranging from a low of $542.08 to a high of $542.09 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Grant of option to buy 24,501 shares of Issuer common stock that became exercisable in five annual installments beginning December 5, 2014 without giving effect to the 2-for-1 stock split of IDEXX Laboratories, Inc. common stock that occurred on June 15, 2015 (the "Stock Split"). The number of derivative securities reported as beneficially owned with respect to this option and its exercise price were adjusted to reflect the Stock Split.
Not applicable.
/s/ Lily J. Lu, Attorney-in-Fact for Jonathan Jay Mazelsky
2021-02-19